{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:14:23Z","timestamp":1781003663921,"version":"3.54.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,20]]},"DOI":"10.7759\/cureus.71938","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T17:21:28Z","timestamp":1729444888000},"source":"Crossref","is-referenced-by-count":3,"title":["Impending Respiratory Failure in Miller Fisher Syndrome: A Report of a Unique Case"],"prefix":"10.7759","author":[{"given":"Sondos","family":"Badran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny S","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renard","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkis","family":"Arabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1250774","article-title":"Miller Fisher syndrome: an updated narrative review","volume":"14","author":"Noioso CM","year":"2023","unstructured":"Noioso CM, Bevilacqua L, Acerra GM, et al.. Miller Fisher syndrome: an updated narrative review. Front Neurol. 2023, 14:10.3389\/fneur.2023.1250774","journal-title":"Front Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-018-3580-2","article-title":"Atypical clinical manifestations of Miller Fisher syndrome","volume":"40","author":"Jung JH","year":"2019","unstructured":"Jung JH, Oh EH, Shin JH, Kim DS, Choi SY, Choi KD, Choi JH. Atypical clinical manifestations of Miller Fisher syndrome. Neurol Sci. 2019, 40:67-73. 10.1007\/s10072-018-3580-2","journal-title":"Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3431849","article-title":"Miller-Fisher syndrome: are Anti-GAD antibodies implicated in its pathophysiology?","volume":"2016","author":"Dagklis IE","year":"2016","unstructured":"Dagklis IE, Papagiannopoulos S, Theodoridou V, Kazis D, Argyropoulou O, Bostantjopoulou S. Miller-Fisher syndrome: are Anti-GAD antibodies implicated in its pathophysiology?. Case Rep Neurol Med. 2016, 2016:10.1155\/2016\/3431849","journal-title":"Case Rep Neurol Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-022-01940-1","article-title":"Clinical and antibodies analysis of anti-GQ1b antibody syndrome: a case series of 15 patients","volume":"123","author":"Wu X","year":"2023","unstructured":"Wu X, Wang Y, Xi ZQ. Clinical and antibodies analysis of anti-GQ1b antibody syndrome: a case series of 15 patients. Acta Neurol Belg. 2023, 123:839-47. 10.1007\/s13760-022-01940-1","journal-title":"Acta Neurol Belg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5811\/cpcem.2020.7.48507","article-title":"Miller-Fisher syndrome: a case report and review of the literature","volume":"4","author":"Truong J","year":"2020","unstructured":"Truong J, Conley J, Ashurst J. Miller-Fisher syndrome: a case report and review of the literature. Clin Pract Cases Emerg Med. 2020, 4:653-5. 10.5811\/cpcem.2020.7.48507","journal-title":"Clin Pract Cases Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217085","article-title":"Miller Fisher syndrome","volume":"2016","author":"Gupta SK","year":"2016","unstructured":"Gupta SK, Jha KK, Chalati MD, Alashi LT. Miller Fisher syndrome. BMJ Case Rep. 2016, 2016:10.1136\/bcr-2016-217085","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2021.1916045","article-title":"An atypical case of Miller Fisher syndrome with multiple autoimmunity","volume":"46","author":"Mercado C","year":"2022","unstructured":"Mercado C, Perez-Rueda M. An atypical case of Miller Fisher syndrome with multiple autoimmunity. Neuroophthalmology. 2022, 46:122-5. 10.1080\/01658107.2021.1916045","journal-title":"Neuroophthalmology"},{"key":"ref8","article-title":"Unusual presentation of Miller Fisher variant syndrome","volume":"42","author":"Alqahtani SA","year":"2020","unstructured":"Alqahtani SA, Alnaami I, Shubaili M, Alqahtani MS. Unusual presentation of Miller Fisher variant syndrome. Bahrain Med Bull. 2020, 42:310-12.","journal-title":"Bahrain Med Bull"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008630.pub5","article-title":"Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"1","author":"Doets AY","year":"2020","unstructured":"Doets AY, Hughes RA, Brassington R, Hadden RD, Pritchard J. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2020, 1:10.1002\/14651858.CD008630.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn PA","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2008, 7:939-50. 10.1016\/S1474-4422(08)70215-1","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0b013e3181f3dbbf","article-title":"Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barr\u00e9 syndrome: critical reassessment of effectiveness and cost-efficiency","volume":"12","author":"Oczko-Walker M","year":"2010","unstructured":"Oczko-Walker M, Manousakis G, Wang S, Malter JS, Waclawik AJ. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barr\u00e9 syndrome: critical reassessment of effectiveness and cost-efficiency. J Clin Neuromuscul Dis. 2010, 12:55-61. 10.1097\/CND.0b013e3181f3dbbf","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1003800225","article-title":"Plasmapheresis treatment in Guillain-Barr\u00e9 syndrome: potential benefit over intravenous immunoglobulin","volume":"38","author":"Buzzigoli SB","year":"2010","unstructured":"Buzzigoli SB, Genovesi M, Lambelet P, Logi C, Raffaelli S, Cattano D. Plasmapheresis treatment in Guillain-Barr\u00e9 syndrome: potential benefit over intravenous immunoglobulin. Anaesth Intensive Care. 2010, 38:387-9. 10.1177\/0310057X1003800225","journal-title":"Anaesth Intensive Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/286102-impending-respiratory-failure-in-miller-fisher-syndrome-a-report-of-a-unique-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T17:21:29Z","timestamp":1729444889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/286102-impending-respiratory-failure-in-miller-fisher-syndrome-a-report-of-a-unique-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,20]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.71938","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,20]]}}}